Exploring missed opportunities for influenza vaccination and influenza vaccine co-administration patterns among Italian older adults: a retrospective cohort study

被引:7
|
作者
Domnich, Alexander [1 ]
Orsi, Andrea [1 ,2 ,3 ]
Ogliastro, Matilde [2 ]
Trombetta, Carlo-Simone [2 ]
Scarpaleggia, Marianna [2 ]
Ceccaroli, Chiara [4 ]
Amadio, Carla [4 ]
Raffo, Anna [4 ]
Berisso, Luca [4 ]
Yakubovich, Alla [4 ]
Zappa, Giacomo [4 ]
Amicizia, Daniela [1 ,3 ,5 ]
Panatto, Donatella [1 ,3 ]
Icardi, Giancarlo [1 ,3 ]
机构
[1] IRCCS Oncol & Neurosci, San Martino Policlin Hosp, Hyg Unit, Largo Rosanna Benzi 10, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Hlth Sci DISSAL, Genoa, Italy
[3] Interuniv Res Ctr Influenza & Other Transmissible, Genoa, Italy
[4] Local Hlth Unit 3 ASL3, Genoa, Italy
[5] Reg Hlth Agcy Liguria ALiSa, Genoa, Italy
来源
EUROPEAN JOURNAL OF PUBLIC HEALTH | 2023年 / 33卷 / 06期
关键词
PNEUMOCOCCAL POLYSACCHARIDE VACCINE; CONJUGATE VACCINE; AGED; 50; IMMUNOGENICITY; SAFETY; RATES;
D O I
10.1093/eurpub/ckad155
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Missed opportunities constitute a main driver of suboptimal seasonal influenza vaccination (SIV) coverage in older adults. Vaccine co-administration is a way to reduce these missed opportunities. In this study, we quantified missed opportunities for SIV, identified some of their socio-structural correlates and documented SIV co-administration patterns. Methods: In this registry-based retrospective cohort study, we verified the SIV status of all subjects aged >= 65 years who received at least one dose of coronavirus disease 2019 (COVID-19), pneumococcal or herpes zoster vaccines during the 2022/23 influenza season. The frequency of concomitant same-day administration of SIV with other target vaccines was also assessed. Results: Among 41 112, 5482 and 3432 older adults who received >= 1 dose of COVID-19, pneumococcal and herpes zoster vaccines, missed opportunities for SIV accounted for 23.3%, 5.0% and 13.2%, respectively. Younger, male and foreign-born individuals were generally more prone to missing SIV. The co-administration of SIV with other recommended vaccines was relatively low, being 11.0%, 53.1% and 17.1% in COVID-19, pneumococcal and herpes zoster cohorts, respectively. Conclusions: A sizeable proportion of older adults who received other recommended vaccines during the last influenza season did not receive SIV. This share of missed opportunities, which are subject to some social inequalities, may be addressed by increasing vaccine co-administration rates and implementing tailored health promotion interventions.
引用
收藏
页码:1183 / 1187
页数:5
相关论文
共 50 条
  • [41] Effect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007-2012
    Gallini, Adeline
    Coley, Nicola
    Andrieu, Sandrine
    Lapeyre-Mestre, Maryse
    Gardette, Virginie
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 (04) : 471 - 480
  • [42] Estimating influenza vaccine effectiveness among older adults using an integrated administrative database and the implications of potential bias: A population-based cohort study in Japan
    Kasamatsu, Ayu
    Yahata, Yuichiro
    Fukushima, Wakaba
    Sakamoto, Hirofumi
    Tanaka, Kaori
    Takigawa, Miwa
    Izu, Kaori
    Nishino, Yuko
    Suzuki, Motoi
    Kamiya, Hajime
    VACCINE, 2024, 42 (26)
  • [43] Safety Assessment of Influenza Vaccination for Neurological Outcomes Among Older Adults in Japan: A Self-Controlled Case Series Study
    Ogawa, Mitsunori
    Takeuchi, Yoshinori
    Iida, Yukino
    Iwagami, Masao
    Uemura, Kohei
    Ono, Sachiko
    Michihata, Nobuaki
    Koide, Daisuke
    Matsuyama, Yutaka
    Yasunaga, Hideo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2025, 34 (01)
  • [44] Effect of race and ethnicity on influenza vaccine uptake among older US Medicare beneficiaries: a record-linkage cohort study
    Mahmud, Salaheddin M.
    Xu, Liou
    Hall, Laura Lee
    Puckrein, Gary
    Thommes, Edward
    Loiacono, Matthew M.
    Chit, Ayman
    LANCET HEALTHY LONGEVITY, 2021, 2 (03): : E143 - E153
  • [45] Trajectories of seasonal influenza vaccine uptake among French people with diabetes: a nationwide retrospective cohort study, 2006-2015
    Bocquier, Aurelie
    Cortaredona, Sebastien
    Fressard, Lisa
    Loulergue, Pierre
    Raude, Jocelyn
    Sultan, Ariane
    Galtier, Florence
    Verger, Pierre
    BMC PUBLIC HEALTH, 2019, 19 (1)
  • [46] Uptake and correlates of influenza vaccine among older adults residing in rural regions of south China: a cross-sectional study
    Zhao, Peizhen
    Xu, Wenqian
    Wang, Jinshen
    Liang, Peng
    Li, Haiyi
    Wang, Cheng
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [47] Effect of Current-Season-Only Versus Continuous Two-Season Influenza Vaccination on Mortality in Older Adults: A Propensity-Score-Matched Retrospective Cohort Study
    Sun, Huimin
    Wang, Yijing
    Wei, Yongyue
    Hu, Weihua
    Zhou, Junwen
    Nama, Nuosu
    Ma, Yujie
    Liu, Gang
    Hao, Yuantao
    VACCINES, 2025, 13 (02)
  • [48] Effect of influenza vaccine subsidies for older adults on vaccination coverage and mortality before and during the COVID-19 pandemic: an ecological study in Japan
    Ando, T.
    Ibuka, Y.
    Goto, R.
    Haruta, J.
    Le, D. D.
    Fujishima, S.
    PUBLIC HEALTH, 2023, 224 : 152 - 158
  • [49] Real-world effectiveness of influenza vaccination in older adults in the UK from 1997-2012: A quasi-experimental cohort study
    Henley, William E.
    Streeter, Adam J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 13 - 14
  • [50] Patient and practice level factors associated with seasonal influenza vaccine uptake among at-risk adults in England, 2011 to 2016: An age-stratified retrospective cohort study
    Loiacono, Matthew M.
    Mahmud, Salaheddin M.
    Chit, Ayman
    van Aalst, Robertus
    Kwong, Jeffrey C.
    Mitsakakis, Nicholas
    Skinner, Luke
    Thommes, Edward
    Bricout, Helene
    Grootendorst, Paul
    VACCINE: X, 2020, 4